System-Wide Investments Enhance HIV, TB and Malaria Control in Malawi and Deliver Greater Health Impact

Résumé

Summary Global health initiatives have expanded access to treatment for infectious diseases - especially HIV, tuberculosis, and malaria (HTM) - in low- and middle-income countries. However, these “vertically”-funded programs often operate within fragile health systems, where workforce shortages and supply chain failures constrain their effectiveness and sustainability 1,2 . Meanwhile, evaluating the health impact and value-for- money of “horizontal” investments in systems, such as supply chain strengthening or boosting healthcare workforce, and their synergies with vertical programs (through “diagonal” investments combining both) - remains challenging because their benefits are mediated through improvements in many aspects of healthcare delivery and are therefore difficult to measure 3 . Using a dynamic microsimulation model of Malawi’s healthcare system, we show that a diagonal investment approach yields a four-fold greater health impact, measured in disability-adjusted life years (DALYs) averted, than the vertical approach. This approach not only improves health outcomes for non-HTM causes of DALYs but also amplifies the effect on DALYs caused by HTM. Additionally, diagonal investments offer greater value for money and a 24.94% higher return on investment (6.67 [5.81 - 6.85] compared with 5.34 [3.44 - 6.24]), even after accounting for their additional costs. Our findings demonstrate that HSS investments generate synergistic effects, amplifying the benefits of GHIs while also strengthening broader healthcare delivery. These results support a shift toward more integrated global health financing strategies.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0